文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期，新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

GLS2 shapes ferroptosis in hepatocellular carcinoma.

作者信息

Suzuki Sawako, Venkatesh Divya, Tanaka Tomoaki, Prives Carol

出版信息

Oncotarget. 2023 Oct 19;14:900-903. doi: 10.18632/oncotarget.28526.

DOI:10.18632/oncotarget.28526
PMID:37861381
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10588662/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0323/10588662/0a3a3b84112c/oncotarget-14-28526-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0323/10588662/c26969ab2879/oncotarget-14-28526-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0323/10588662/0a3a3b84112c/oncotarget-14-28526-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0323/10588662/c26969ab2879/oncotarget-14-28526-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0323/10588662/0a3a3b84112c/oncotarget-14-28526-g002.jpg

相似文献

[1]
GLS2 shapes ferroptosis in hepatocellular carcinoma.

Oncotarget. 2023-10-19

[2]
GLS2 Is a Tumor Suppressor and a Regulator of Ferroptosis in Hepatocellular Carcinoma.

Cancer Res. 2022-9-16

[3]
Glutaminase 2 negatively regulates the PI3K/AKT signaling and shows tumor suppression activity in human hepatocellular carcinoma.

Oncotarget. 2014-5-15

[4]
Kidney-type glutaminase (GLS1) is a biomarker for pathologic diagnosis and prognosis of hepatocellular carcinoma.

Oncotarget. 2015-4-10

[5]
Glutaminase 2 stabilizes Dicer to repress Snail and metastasis in hepatocellular carcinoma cells.

Cancer Lett. 2016-12-28

[6]
ZNF498 promotes hepatocellular carcinogenesis by suppressing p53-mediated apoptosis and ferroptosis via the attenuation of p53 Ser46 phosphorylation.

J Exp Clin Cancer Res. 2022-2-28

[7]
Glutaminase 2 is a novel negative regulator of small GTPase Rac1 and mediates p53 function in suppressing metastasis.

Elife. 2016-1-11

[8]
Ferroptosis and hepatocellular carcinoma: the emerging role of lncRNAs.

Front Immunol. 2024

[9]
Ferroptosis in hepatocellular carcinoma: mechanisms and targeted therapy.

Br J Cancer. 2023-1

[10]
Epigenetic silencing of glutaminase 2 in human liver and colon cancers.

BMC Cancer. 2013-12-14

引用本文的文献

[1]
Glutamine and leukemia research: progress and clinical prospects.

Discov Oncol. 2024-8-31

本文引用的文献

[1]
GLS2 Is a Tumor Suppressor and a Regulator of Ferroptosis in Hepatocellular Carcinoma.

Cancer Res. 2022-9-16

[2]
The Regulation of Ferroptosis by Tumor Suppressor p53 and its Pathway.

Int J Mol Sci. 2020-11-9

[3]
Atezolizumab plus Bevacizumab in Unresectable Hepatocellular Carcinoma.

N Engl J Med. 2020-5-14

[4]
Lenvatinib versus sorafenib in first-line treatment of patients with unresectable hepatocellular carcinoma: a randomised phase 3 non-inferiority trial.

Lancet. 2018-3-24

[5]
The African-specific S47 polymorphism of p53 alters chemosensitivity.

Cell Cycle. 2016-10

[6]
An African-specific polymorphism in the TP53 gene impairs p53 tumor suppressor function in a mouse model.

Genes Dev. 2016-4-15

[7]
Glutaminolysis and Transferrin Regulate Ferroptosis.

Mol Cell. 2015-7-16

[8]
Ferroptosis as a p53-mediated activity during tumour suppression.

Nature. 2015-4-2

[9]
Iron-dependent cell death of hepatocellular carcinoma cells exposed to sorafenib.

Int J Cancer. 2013-4-8

[10]
Tumor suppression in the absence of p53-mediated cell-cycle arrest, apoptosis, and senescence.

Cell. 2012-6-8

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索